Gastrointestinal stromal tumours (GIST) in children: An update of this orphan disease

Victoria Min; Nadège Corradini; Nicolas Macagno; Daniel Orbach; Yves Réguerre; Philippe Petit; Jean Yves Blay; Arnauld Verschuur

doi:10.1016/j.bulcan.2024.07.011

Related publications

Article2021

Gastrointestinal stromal tumours

Jean Yves Blay, Yoon‐Koo Kang, Toshiroo Nishida, Margaret von Mehren

Letter2020

Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

Jean Yves Blay, Margaret von Mehren

Article2020

1622MO Clinical benefit with ripretinib as ≥4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study

John Zalcberg, Michael C. Heinrich, Suzanne George, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, César Serrano, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Nicole Meade, V. Reichert, Kelvin Shi, Rodrigo Ruiz‐Soto, Margaret von Mehren, Jean Yves Blay

Article2021

Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Jean Yves Blay, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Angela Buonadonna, Enrique de Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Anna Maria Frezza, Silvia Gasperoni,

Preprint2022

Deep learning predicts patients’ outcome and mutations from H&amp;E slides in Gastrointestinal stromal tumor (GIST)

Yu Fu, Marie Karanian, Raul Perret, Axel Camara, François Le Loarer, Myriam Jean‐Denis, Isabelle Hostein, Audrey Michot, Françoise Ducimetière, Antoine Giraud, Jean-Baptiste Courrèges, Kevin Courtet, Yec’han Laizet, Etienne Bendjebbar, Jean Ogier du Terrail, Benoît Schmauch, Charles Maussion, Jean Yves Blay, Antoîne Italiano, Jean‐Michel Coindre

Gastrointestinal stromal tumours (GIST) in children: An update of this orphan disease

Discussion(0)

Related publications

Gastrointestinal stromal tumours

Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

1622MO Clinical benefit with ripretinib as ≥4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study

Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Deep learning predicts patients’ outcome and mutations from H&amp;amp;E slides in Gastrointestinal stromal tumor (GIST)

Deep learning predicts patients’ outcome and mutations from H&E slides in Gastrointestinal stromal tumor (GIST)